Integration of cardiac myofilament activity and regulation with pathways signaling hypertrophy and failure

Annals of Biomedical Engineering

Volumn 28, Issue 8, 2000, Pages 991-1001

  De Tombe, Pieter P ^a   Solaro, R John ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR SYSTEM; CELLS; DISEASES; GROWTH KINETICS; HEMODYNAMICS; PATHOLOGY; PHYSIOLOGY; TISSUE;

CARDIAC PUMP FUNCTION; CIRCULATORY DISEASES; CONGESTIVE HEART FAILURE; HYPERTROPHY; MYOCARDIUM;

BIOMECHANICS;

CALCIUM; TROPOMYOSIN; TROPONIN;

ANIMAL; CARDIOMEGALY; CONGESTIVE HEART FAILURE; DISEASE COURSE; DOG; DRUG EFFECT; HEART MUSCLE; HEART VENTRICLE REMODELING; HUMAN; MECHANICAL STRESS; METABOLISM; MICROFILAMENT; PATHOPHYSIOLOGY; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CARDIOMEGALY; DISEASE PROGRESSION; DOGS; HEART FAILURE, CONGESTIVE; HUMANS; MICROFILAMENTS; MYOCARDIUM; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; TROPOMYOSIN; TROPONIN; VENTRICULAR REMODELING;

EID: 0034352175     PISSN: 00906964     EISSN: None     Source Type: Journal    
DOI: 10.1114/1.1312189     Document Type: Article

References (101)

1. Alpert, N. R. Myocardial Hypertrophy and Failure. New York: Raven, 1983.
2. Alpert, N. R., and M. S. Gordon. Myofibrillar adenosine triphosphatase activity in congestive heart failure. Am. J. Physiol. 202:940-946, 1962.
3. Alvarez, B. V., N. G. Perez, I. L. Ennis, M. C. Camilion de Hurtado, and H. E. Cingolani. Mechanisms underlying the increase in force and Ca(2+) transient that follow stretch of cardiac muscle: a possible explanation of the Anrep effect. Circ. Res. 85:716-22, 1999.
4. Anderson, P. A. W., A. Greig, T. M. Mark, N. N. Malouf, A. E. Oakeley, R. M. Ungerleider, P. D. Allen, and B. K. Kay. Molecular basis of human cardiac troponin T isoforms expressed in the developing, adult, and failing heart. Circ. Res. 76:681-686, 1995.
5. Anderson, P. A. W., N. N. Malouf, A. E. Oakeley, E. D. Pagani, and P. D. Allen. Troponin-T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ. Res. 69:1226-1233, 1991.
6. 2+ activation. Biochemistry 33:8464-8471, 1994.
7. Barinaga, M. Tracking down mutations that can stop the heart. Science 281:32-34, 1998.
8. Bartel, S., B. Stein, T. Eschenhagen, U. Mende, J. Neumann, W. Schmitz, E. G. Krause, P. Karczewski, and H. Scholz. Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts.Mol. Cell. Biochem. 157:171-179, 1996.
9. Blaufarb, I. S., and E. H. Sonnenblick. The renin-angiotensin system in left ventricular remodeling. Am. J. Cardiol. 77:8C-16C, 1996.
10. Bodor, G. S., A. E. Oakeley, P. D. Allen, D. L. Crimmins, J. H. Ladenson, and P. A. Anderson. Troponin I phosphorylation in the normal and failing adult human heart. Circulation. 96:1495-1500, 1997.
11. Bowman, J. C., S. F. Steinberg, T. Jiang, D. L. Geenen, G. I. Fishman, and P. M. Buttrick. Expression of protein kinase C beta in the heart causes hypertrophy in adult mice arid sudden death in neonates. J. Clin. Invest. 100:2189-2195, 1997.
12. Brady, A. J. Mechanical properties of isolated cardiac myocytes. Physiol. Rev. 71:413-428, 1991.
13. Cingolani, H. E., B. V. Alvarez, I. L. Ennis, and M. C. Camilion de Hurtado. Stretch-induced alkalinization of feline papillary muscle: an autocrine-paracrine system. Circ. Res. 83:775-778, 1998.
14. CONSENSUS. Effects enalapril on mortality in severe congestive heart failure. N. Engl. J. Med. 316:1429-1435, 1987.
15. 2+ release activity of the sarcoplasmic reticulum in dilated cardiomyopathy. Circulation 85:518-525, 1992.
16. D'Angelo, D. D., Y. Sakata, J. N. Lorenz, G. P. Boivin, R. A. Walsh, S. B, Liggett, and G. W. Dorn, 2nd. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc. Natl. Acad. Sci. U.S.A. 94:8121-8126, 1997.
17. de Tombe, P. P., and G. J. M. Stienen. Protein kinase A does not alter economy of force maintenance in skinned rat cardiac trabeculae. Circ. Res. 76:734-741, 1995.
18. de Tombe, P. P., and H. E. D. J. ter Keurs. Lack of effect of isoproterenol on unloaded velocity of sarcomere shortening in rat cardiac trabeculae. Circ. Res. 68:382-391, 1991.
19. de Tombe, P. P., T. Wannenburg, D. Fan, and W. C. Little. Right ventricular contractile protein function in rats with left ventricular myocardial infarction. Am. J. Physiol. 271:H73-H79, 1996.
20. + response amplitude and duration. Nature (London) 386:855-858, 1997.
21. Dolmetsch, R. E., K. Xu, and R. S. Lewis. Calcium oscillations increase the efficiency and specificity of gene expression. Nature (London) 392:933-936, 1998.
22. Eichhorn, E. J., and M. R. Brostow. Medical therapy can improve the biological properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation 94:2285-2296, 1996.
23. Fan, D. S., T. Wannenburg, and P. P. de Tombe. Decreased myocyte tension development and calcium responsiviness in rat right ventricular pressure overload. Circulation 95:2312-2317, 1997.
24. Feldman, M. D., L. Copelas, J. K. Gwathmey, P. Phillips, S. E. Warren, F. J. Schoen, W. Grossman, and J. P. Morgan. Deficient production of cyclic AMP: pharmacologic evidence of and important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75:331-339, 1987.
25. Francis, G. S., and J. N. Cohn. Heart failure: Mechanisms of cardiac and vascular dysfunction and the rationale for pharmacologic intervention. FASEB J. 4:3068-3075, 1990.
26. Geenen, D. L., A. Malhotra, and J. Scheuer. Regional variation in rat cardiac myosin isoenzymes and ATPase activity after infarction. Am. J. Phys. 256:H745-H750, 1989.
27. Gruver, C. L., F. DeMayo, M. A. Goldstein, and A. R. Means. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology 133:376-388, 1993.
28. Gu, X., and S. P. Bishop. Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ. Res. 75:926-931, 1994.
29. Gulati, J., A. B. Akella, S. D. Nikolic, V. Starc, and F. Siri. Shifts in contractile regulatory protein subunits troponin T and troponin I in cardiac hypertrophy. Biochem. Biophys. Res. Commun. 202:384-390, 1994.
30. 2+. Circulation 82:1266-1278, 1990.
31. Hajjar, R. J., and J. K. Gwathmey. Cross-bridge dynamics in human ventricular myocardium: Regulation of contractility in the failing heart. Circulation 86:1819-1826, 1992.
32. Hajjar, R. J., J. X. Kang, J. K. Gwathmey, and A. Rosenzweig. Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum ATPase in isolated rat myocytes. Circulation 95:423-429, 1997.
33. ++ sensitizers impair cardiac relaxation in human myocardium. J. Pharm. Exp. Ther. 280:247-254, 1997.
34. Hill, A. V. The heat of shortening and the dynamic constants of muscle. Proc. R. Soc. London., Ser. B. 126:1366-1195, 1938.
35. Hofmann, P. A., and J. H. Lange, III. Effects of phosphorylation of troponin I and C protein on isometric tension and velocity of unloaded shortening in skinned single cardiac myocytes from rats. Circ. Res. 74:718-726, 1994.
36. Hofmann, P. A., and R. L. Moss. Effects of calcium on shortening velocity in frog chemically skinned atrial myocytes and in mechanically disrupted ventricular myocardium from rat. Circ. Res. 70:885-892, 1992.
37. +] and pH in rat skinned cardiac myocytes. Am. J. Physiol. H269:H1656-H1663, 1995.
38. Holroyde, M. J., D. A. Small, E. Howe, and R. J. Solaro. Isolation of cardiac myofibrils and myosin light chains with in vivo levels of light chain phosphorylation. Biochim. Biophys. Acta 587:628-637, 1979.
39. Holubarsch, C., T. Ruf, D. J. Goldstein, R. C. Ashton, W. Nickl, B. Pieske, K. Pioch, J. Ludemann, S. Wiesner, G. Hasenfuss. H. Posival, H. Just, and D. Burkhoff. Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. Circulation 94:683-689, 1996.
40. Hunkeler, N. M., J. Kullman, and A. M. Murphy. Troponin-I isoform expression in human heart. Circ. Res. 69:1409-1414, 1991.
41. + exchange is impaired in cardiac hypertrophy. J. Clin. Invest. 99:125-135, 1997.
42. Janssen, P. M., and P. P. de Tombe. Protein kinase A does not alter unloaded velocity of sarcomere shartening in skinned rat cardiac trabeculae. Am. J. Physiol. 273:H2415-H2422, 1997.
43. Jeck, C. D., R. Zimmermann, J. Schaper, and W. Schaper. Decreased expression of calmodulin mRNA in human end-stage heart failure. J. Mol Cell. Cardiol. 26:99-107, 1994.
44. Kentish, J. C., H. E. D. J. ter Keurs, L. Ricciardi, J. J. J. Bucx, and M. I. M. Noble. Comparison between the sarcomere length-force relations of intact and skinned trabeculae from rat right ventricle: influence of calcium concentrations on these relations. Circ. Res. 58:755-768, 1986.
45. +)-tension relationship in aequorin-injected ferret papillary muscles. Am. J. Physiol. 273:H1068-H1074, 1997.
46. Konhilas, J., B. M. Wolska, A. F. Martin, K. A. Palmiter, J. M. Leiden, R. Fentzke, R. J. Solaro, and P. P. de Tombe. Tropnin I isoform composition modulates length dependent activation in murine myocardium. Circulation 98:I-836, 1998.
47. Li, P., P. A. Hofmann, B. S. Li, A. Malhotra, W. Cheng, E. H. Sonnenblick, L. G. Meggs, and P. Anversa. Myocardial infarction alters myofilament calcium sensitivity and mechanical behavior of myocytes. Am. J. Physiol. :H360-H370, 1997.
48. Liu, X. L., Q. M. Shao, and N. S. Dhalla. Myosin light chain phosphorylation in cardiac hypertrophy and failure due to myocardial infarction. J. Mol. Cell. Cardiol. 27:2613-2621, 1995.
49. Malhotra, A., M. C. Lopez, and A. Nakouzi. Troponin subunits contribute to altered myosin ATPase activity in diabetic cardiomyopathy. Mol. Cell. Biochem. 151:165-172, 1995.
50. Malhotra, A., A. Nakouzi, J. Bowman, and P. Buttrick. Expression and regulation of mutant forms of cardiac TnI in a reconstituted actomyosin system: role of kinase dependent phosphorylation. Mol. Cell. Biochem. 170:99-107, 1997.
51. Malhotra, A., D. Reich, A. Nakouzi, V. Sanghi, D. L. Geenen, and P. M. Buttrick. Experimental diabetes is associated with functional activation of protein kinase C epsilon and phosphorylation of troponin I in the heart, which are prevented by angiotensin II receptor blockade. Circ. Res. 81:1027-1033, 1997.
52. Margossian, S. S., H. D. White, J. B. Caulfield, P. Norton, S. Taylor, and H. S. Slayter. Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy: Identification of a causal agent for impaired myocardial function. Circulation 85:1720-1733, 1992.
53. Meij, J. T. A., V. Panagia, N. Mesaeli, J. L. Peachell, N. Afzal, and N. S. Dhalla. Identification of changes in cardiac phospholipase C activity in congestive heart failure. J. Mol. Cell. Cardiol. 29:237-246, 1997.
54. Mercadier, J. J., P. Bouverett, L. Gorza, S. Schiaffino, W. A. Clark, R. Zak, B. Swynghedauw, and K. Schwartz. Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ. Res. 53:52-62, 1983.
55. Miyata, S., W. Minobe, M. R. Bristow, and L. A. Leinwand. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ. Res. 86:386-390, 2000.
56. Molkentin, J. D., J. R. Lu, C. L. Antos, B. Markham, J. Richardson, J. Robbins, S. R. Grant, and E. N. Olson. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228, 1998.
57. Morano, I., O. Ritter, A. Bonz, T. Timek, C. F. Vahl, and G. Michel. Myosin light chain-actin interaction regulates cardiac contractility. Circ. Res. 76:720-725, 1995.
58. 2+ regulation of mechanical properties of striated muscle: Mechanistic studies using extraction and replacement of regulatory proteins. Circ. Res. 70:865-884, 1992.
59. Nadal-Ginard, B., and V. Mahdavi. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J. Clin. Invest. 84:1693-1700, 1989.
60. Nakao, K., W. Minobe, R. Roden, M. R. Bristow, and L. A. Leinwand. Myosin heavy chain gene expression in human heart failure. J. Clin. Invest. 100:2362-2370, 1997.
61. Nassar, R., N. N. Malouf, M. B. Kelly, A. E. Oakeley, and P. A. Anderson. Force-pCa relation and troponin T isoforms of rabbit myocardium. Circ. Res. 69:1470-1475, 1991.
62. Naya, T., V. Manaves, Y. Mori, M. C. G. Daniels, V. L. M. Rundell, and P. P. de Tombe. Cross-bridge cycling rate during the development of heart failure. Biophys. J. 78:108A, 2000.
63. Nielsen-Kudsk, J. E., and J. Aldershville. Will calcium sensitizers play a role in the treatment of heart failure? J. Cardiovasc. Pharmacol. 26:S77-S84, 1995.
64. 2+-stimulated MgATPase of reconstituted actomyosin S-1. J. Biol. Chem. 270:25445-25454, 1995.
65. Pagani, E. D., A. A. Alousi, A. M. Grant, T. M. Older, S. W. Dziuban, and P. D. Allen. Changes in myofibrillar content and Mg-ATPase activity in ventricular tissue from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. Circ. Res. 63:380-385, 1988.
66. 2+ activation and relaxation in rat and guinea pig skinned trabeculae. Circ. Res. 83:179-186, 1998.
67. Palmer, R. E., A. J. Brady, and K. P. Roos. Mechanical measurements from isolated cardiac myocytes using a pipette attachment system. Am. J. Physiol. Cell Physiol. 270:C697-C704, 1996.
68. +: implications of mutations causal for familial hypertrophic cardiomyopathy. Basic Res. Cardiol. 92:63-74, 1997.
69. Paul, K., N. A. Ball, G. W. Dorn, 2nd., and R. A. Walsh. Left ventricular stretch stimulates angiotensin II-mediated phosphatidylinositol hydrolysis and protein kinase C epsilon isoform translocation in adult guinea pig hearts. Circ. Res. 81:643-650, 1997.
70. Perreault, C. L., O. H. L. Bing, W. W. Brooks, B. J. Ransil, and J. P. Morgan. Differential effects of cardiac hypertrophy and failure on right versus left ventricular calcium activation. Circ. Res. 67:707-712, 1990.
71. +)-independent regulation of contractility in isolated human myocardium. Basic Res. Cardiol. 92:75-86, 1997.
72. Pope, B., J. Hoh, and A. Weed. The ATPase activities of rat cardiac myosin isoenzymes. FEBS Lett. 118:205-208, 1980.
73. Rall, J. A. Sense and nonsense about the Fenn effect. Am. J. Physiol. 242:H1-H6, 1982.
74. Rarick, H. M., H. Tang, X. Guo, A. F. Martin, and R. J. Solaro. Interactions at the NH2-terminal interface of cardiac troponin I modulate myofilament activation. J. Mol. Cell. Cardiol. 31:363-375, 1999.
75. +-regulatory site of bovine cardiac troponin. J. Biol. Chem. 257:260-263, 1982.
76. Ruf, T., H. Schulte-Baukloh, J. Ludemann, H. Posival, H. Just, and C. Holubarsch. Alterations of cross-bridge kinetics in human atrial and ventricular myocardium. Cardiovasc. Res. 40:580-590, 1998.
77. Saeki, Y., T. Kobayashi, S. Minamisawa, and H. Sugi. Protein kinase A increases the tension cost and unloaded shortening velocity in skinned rat cardiac muscle. J. Mol. Cell. Cardiol. 29:1655-1663, 1997.
78. Sakata, Y., B. D. Hoit, S. B. Liggett, R. A. Walsh, and G. W. Dorn, 2nd. Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice [see comments]. Circulation 97:1488-1495, 1998.
79. Sasse, S., N. J. Brand, P. Kyprianou, G. K. Dhoot, R. Wade, M. Arai, M. Periasamy, M. H. Yacoub, and P. J. R. Barton. Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ. Res. 72:932-938, 1993.
80. Sato, Y., D. G. Ferguson, H. Sako, G. W. Dorn, 2nd., V. J. Kadambi, A. Yatani, B. D. Hoit, R. A. Walsh, and E. G. Kranias. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J. Biol. Chem. 273:28470-28477, 1998.
81. Schwartz, K., K. R. Boheler, D. de la Bastie, A.-M. Lompre, and J.-J. Mercadier. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am. J. Physiol Regul. Integr. Comp. Physiol. 262:R364-R369 1992.
82. Schwinger, R. H. G., M. Böhm, A. Koch, U. Schmidt, I. Morano, H.-J. Eissner, P. Überfuhr, B. Reichart, and E. Erdmann. The failing human heart is unable to use the Frank-Starling mechanism. Circ. Res. 74:959-969, 1994.
83. Sharir, T., M. D. Feldman, H. Haber, A. M. Feldman, A. Marmor, L. C. Becker, and D. A. Kass. Ventricular systolic assessment in patients with dilated cardiomyopathy by preload-adjusted maximal power. Validation and noninvasive application. Circulation 89:2045-2053, 1994.
84. Solaro, R. J. Protein Phosphorylation in Heart Muscle. Boca Raton: Chemical Rubber Corp., 1986.
85. Solaro, R. J. Myosin and why hearts fail. Circulation 85:1945-1947, 1992.
86. Solaro, R. J., and H. M. Rarick. Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments. Circ. Res. 83:471-480, 1998.
87. Solaro, R. J., and J. Van Eyk. Altered interactions among thin filament proteins modulate cardiac function. J. Mol. Cell. Cardiol. 28:217-230, 1996.
88. Solaro, R. J., A. J. Moir, and S. V. Perry. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature (London) 262:615-617, 1976.
89. Solaro, R. J., J. A. Lee, J. C. Kentish, and D. G. Allen. Effects of acidosis on ventricular muscle from adult and neonatal rats. Circ. Res. 63:779-787, 1988.
90. 1-adrenergic receptor stimulation decreases maximum shortening velocity of skinned single ventricular myocytes from rats. Circ. Res. 77:114-120, 1995.
91. Strang, K. T., R. M. Mentzer, and R. L. Moss. Slowing of shortening velocity of rat cardiac myocytes by adenosine receptor stimulation regardless of β-adrenergic stimulation. J. Physiol. (London) 486:679-688, 1995.
92. Strang, K. T., N. K. Sweitzer, M. L. Greaser, and R. L. Moss. β-adrenergic receptor stimulation increase unloaded shortening velocity of skinned single ventricular myocytes from rats. Circ. Res. 74:542-549, 1994.
93. Sugden, P. H., and A. Clerk. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76:725-746, 1998.
94. Sütsch, G., U. T. Brunner, C. Von Schulthess, E. O. Hirzel, O. M. Hess, M. Turina, H. P. Krayenbuehl, and M. C. Schaub. Hemodynamic performance and myosin light chain-1 expression of the hypertrophied left ventricle in aortic valve disease before and after valve replacement. Circ. Res. 70:1035-1043, 1992.
95. Swynghedauw, B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscle. Physiol. Rev. 66:710-771, 1986.
96. Takeishi, Y., G. Chu, D. M. Kirkpatrick, Z. Li, H. Wakasaki, E. G. Kranias, G. L. King, and R. A. Walsh. In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J. Clin. Invest. 102:72-78, 1998.
97. Vahl, C. F., A. Bonz, T. Timek, and S. Hagl. Intracellular calcium transient of working human myocardium of seven patients transplanted for congestive heart failure. Circ. Res. 74:952-958, 1994.
98. van Bilsen, M. Signal transduction revisited: recent developments in angiotensin II signaling in the cardiovascular system. Cardiovasc. Res. 36:310-322, 1997.
99. van der Velden, J., A. F. Moorman, and G. J. Stienen. Age-dependent changes in myosin composition correlate with enhanced economy of contraction in guinea-pig hearts. J. Physiol. (London) 507:497-510, 1998.
100. Wolff, M. R., S. H. Buck, S. W. Stoker, M. L. Greaser, and R. M. Mentzer. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. J. Clin. Invest. 98:167-176, 1996.
101. Wolff, M. R., L. F. Whitesell, and R. L. Mess. Calcium sensitivity of isometric tension is increased in canine experimental heart failure. Circ. Res. 76:781-789, 1995.